ScriptCheckWA
ScriptCheckWA
A series of three modules to train prescribers and pharmacists on the use of the Western Australian ScriptCheck system. The first module details the functionality of real-time prescription monitoring (RTPM) and its safety benefits. The second module has a focus on safe and appropriate dispensing of monitored medicines, and managing concerns about patient safety regarding the use of monitored medicines. The third module details best practice communication strategies to help prepare for conversations with patients about monitored medicines.
Although we recommend attempting these modules in sequential order, it is possible to complete the modules in any order and still earn the allocated CPD credit, provided you pass each assessment with a score of 80% or higher.
Target audience: General practitioners, prescribers of monitored medicines and pharmacists in WA
Cost: Free
CPD points: Self-directed CPD – view details
Module 1. The ScriptCheckWA System – what, when and how? (for prescribers and pharmacists)
This module provides an overview of ScriptCheckWA – the Western Australian Government's real-time prescription monitoring system.
It provides you with an opportunity to update your knowledge on the increasing harms from medicines monitored within ScriptCheckWA and to learn how ScriptCheckWA provides additional information to assist with clinical decisions when prescribing or dispensing the medicines monitored within ScriptCheckWA.
The module also outlines ways to manage and maintain patient privacy when using ScriptCheckWA and summarises relevant regulatory requirements for the use of ScriptCheckWA when writing or dispensing a prescription for a monitored medicine.
Module 2. Monitored medicines and clinical practice (for prescribers)
This module provides you with an opportunity to reconsider how you manage safety concerns about patients with prescription medicine dependence or those showing signs of high-risk use. It explores planning approaches for the consultation, strategies for collaboration with other health professionals, whole of practice/service approaches to ensure equity and safety for everyone and provides you with an opportunity to review available management and treatment options.
It will also refresh your knowledge of alternative options for management of chronic pain, anxiety and insomnia, including non-pharmacological approaches and other lower risk pharmacological treatments.
Module 2. Monitored medicines and clinical practice (for pharmacists)
This module provides you with an opportunity to refresh your knowledge on safe and appropriate dispensing of high-risk medicines, particularly those monitored in SafeScript NSW, and reconsider how you manage concerns about patient safety regarding their use of these high-risk medicines.
It will also refresh your knowledge of alternative options for management of chronic pain, anxiety and insomnia, including non-pharmacological approaches and other lower risk pharmacological treatments.
Module 3. Communication and care for patients using monitored medicines (for prescribers and pharmacists)
This module provides foundation information to help you and your practice/pharmacy prepare for conversations with patients about the potential risks of dependence with high-risk medicines. It explores the elements of best practice communication and how to apply effective communication strategies when explaining the risks of long-term use before prescribing or dispensing high-risk medicines. The module also outlines how to implement practice policies, set behaviour standards and use de-escalation techniques to reduce safety risks for health professionals and patients in challenging situations.
Continuing professional development
Although we recommend attempting these modules in sequential order, it is possible to complete the modules in any order.
Self-directed CPD
It is recommended that 1 CPD hour be recorded for each activity for the purposes of self-directed CPD.
